David Risinger
Stock Analyst at Leerink Partners
(4.97)
# 78
Out of 4,421 analysts
1134
Total ratings
63.8%
Success rate
30.3%
Average return
Main Sectors:
Stocks Rated by David Risinger
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ORKA Oruka Therapeutics | Reiterated: Buy | n/a | $72.34 | - | 15 | Jun 2, 2026 | |
| LLY Eli Lilly and Company | Reiterated: Buy | n/a | $1,098.57 | - | 118 | Jun 2, 2026 | |
| ANAB AnaptysBio | Reiterated: Buy | n/a | $57.51 | - | 33 | May 27, 2026 | |
| REGN Regeneron Pharmaceuticals | Downgraded: Hold | $641 | $609.94 | +5.09% | 58 | May 18, 2026 | |
| JNJ Johnson & Johnson | Reiterated: Buy | $201 → $265 | $228.39 | +16.03% | 53 | May 15, 2026 | |
| IMA ImageneBio | Maintained: Buy | $30 → $24 | $6.00 | +300.00% | 2 | May 8, 2026 | |
| TRAX First Tracks Biotherapeutics | Initiated Coverage: Buy | $46 | $17.42 | +164.06% | 1 | Apr 24, 2026 | |
| CNTA Centessa Pharmaceuticals | Downgraded: Hold | $40 | $40.02 | -0.05% | 37 | Apr 1, 2026 | |
| XOMA XOMA Royalty | Maintained: Buy | $50 | $41.89 | +19.36% | 19 | Feb 24, 2026 | |
| AMGN Amgen | Maintained: Hold | n/a | $337.60 | - | 42 | Jan 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $60 | $54.00 | +11.11% | 71 | Jan 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $216.49 | - | 72 | Jan 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $68.55 | - | 37 | Jan 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $525 | $451.63 | +16.25% | 44 | Dec 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $74.14 | - | 58 | Dec 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 → $32 | $31.43 | +1.81% | 47 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $26 | $25.21 | +3.13% | 90 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $51.44 | - | 27 | Oct 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $12.00 | - | 9 | Sep 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $42.38 | - | 1 | Sep 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $30.03 | - | 13 | Sep 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $10.02 | - | 5 | Aug 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $13 | $16.58 | -21.59% | 21 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $60 → $44 | $44.51 | -1.15% | 24 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $27 → $23 | $63.96 | n/a | 2 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $28 | $60.88 | n/a | 1 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $3.54 | n/a | 1 | Jan 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $40.99 | n/a | 1 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $91 | $123.76 | n/a | 12 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $11.37 | n/a | 1 | Mar 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $33 | $13.43 | n/a | 1 | Jun 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $176 | $224.66 | n/a | 12 | May 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $20 → $22 | $31.85 | n/a | 15 | May 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $90 | $113.87 | n/a | 34 | Apr 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $18 → $16 | $15.37 | n/a | 24 | Mar 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $53 → $45 | $10.25 | n/a | 19 | Mar 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $49.51 | $6.57 | n/a | 32 | Feb 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $16 → $22 | $44.99 | n/a | 19 | Dec 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $8 → $9 | $31.48 | n/a | 29 | Dec 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $31 → $41 | $24.22 | n/a | 8 | Nov 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $167 → $174 | $78.71 | n/a | 16 | Nov 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $51 | $52.96 | n/a | 1 | Jul 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $18 → $3 | $16.21 | n/a | 4 | Apr 2, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $271.83 | n/a | 2 | Nov 16, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $36 | $184.29 | n/a | 3 | Sep 21, 2012 |
Oruka Therapeutics
Jun 2, 2026
Reiterated: Buy
Price Target: n/a
Current: $72.34
Upside: -
Eli Lilly and Company
Jun 2, 2026
Reiterated: Buy
Price Target: n/a
Current: $1,098.57
Upside: -
AnaptysBio
May 27, 2026
Reiterated: Buy
Price Target: n/a
Current: $57.51
Upside: -
Regeneron Pharmaceuticals
May 18, 2026
Downgraded: Hold
Price Target: $641
Current: $609.94
Upside: +5.09%
Johnson & Johnson
May 15, 2026
Reiterated: Buy
Price Target: $201 → $265
Current: $228.39
Upside: +16.03%
ImageneBio
May 8, 2026
Maintained: Buy
Price Target: $30 → $24
Current: $6.00
Upside: +300.00%
First Tracks Biotherapeutics
Apr 24, 2026
Initiated Coverage: Buy
Price Target: $46
Current: $17.42
Upside: +164.06%
Centessa Pharmaceuticals
Apr 1, 2026
Downgraded: Hold
Price Target: $40
Current: $40.02
Upside: -0.05%
XOMA Royalty
Feb 24, 2026
Maintained: Buy
Price Target: $50
Current: $41.89
Upside: +19.36%
Amgen
Jan 13, 2026
Maintained: Hold
Price Target: n/a
Current: $337.60
Upside: -
Jan 13, 2026
Maintained: Buy
Price Target: $60
Current: $54.00
Upside: +11.11%
Jan 13, 2026
Maintained: Buy
Price Target: n/a
Current: $216.49
Upside: -
Jan 8, 2026
Maintained: Hold
Price Target: n/a
Current: $68.55
Upside: -
Dec 29, 2025
Maintained: Buy
Price Target: $525
Current: $451.63
Upside: +16.25%
Dec 24, 2025
Maintained: Buy
Price Target: n/a
Current: $74.14
Upside: -
Dec 15, 2025
Reiterated: Buy
Price Target: $22 → $32
Current: $31.43
Upside: +1.81%
Dec 9, 2025
Maintained: Hold
Price Target: $26
Current: $25.21
Upside: +3.13%
Oct 1, 2025
Reiterated: Buy
Price Target: n/a
Current: $51.44
Upside: -
Sep 17, 2025
Maintained: Buy
Price Target: n/a
Current: $12.00
Upside: -
Sep 4, 2025
Reiterated: Buy
Price Target: n/a
Current: $42.38
Upside: -
Sep 1, 2025
Maintained: Buy
Price Target: n/a
Current: $30.03
Upside: -
Aug 17, 2025
Reiterated: Buy
Price Target: n/a
Current: $10.02
Upside: -
Aug 13, 2025
Maintained: Hold
Price Target: $13
Current: $16.58
Upside: -21.59%
Aug 7, 2025
Maintained: Buy
Price Target: $60 → $44
Current: $44.51
Upside: -1.15%
Apr 16, 2025
Maintained: Sell
Price Target: $27 → $23
Current: $63.96
Upside: n/a
Feb 24, 2025
Initiated Coverage: Buy
Price Target: $28
Current: $60.88
Upside: n/a
Jan 17, 2025
Reiterated: Hold
Price Target: n/a
Current: $3.54
Upside: n/a
May 1, 2024
Reiterated: Buy
Price Target: n/a
Current: $40.99
Upside: n/a
Apr 28, 2023
Maintained: Hold
Price Target: $91
Current: $123.76
Upside: n/a
Mar 14, 2023
Maintained: Buy
Price Target: n/a
Current: $11.37
Upside: n/a
Jun 11, 2021
Initiated Coverage: Hold
Price Target: $33
Current: $13.43
Upside: n/a
May 21, 2021
Reiterated: Hold
Price Target: $176
Current: $224.66
Upside: n/a
May 13, 2021
Maintained: Sell
Price Target: $20 → $22
Current: $31.85
Upside: n/a
Apr 1, 2021
Maintained: Buy
Price Target: $90
Current: $113.87
Upside: n/a
Mar 10, 2021
Maintained: Hold
Price Target: $18 → $16
Current: $15.37
Upside: n/a
Mar 5, 2021
Maintained: Hold
Price Target: $53 → $45
Current: $10.25
Upside: n/a
Feb 26, 2021
Maintained: Hold
Price Target: $49.51
Current: $6.57
Upside: n/a
Dec 21, 2020
Maintained: Hold
Price Target: $16 → $22
Current: $44.99
Upside: n/a
Dec 21, 2020
Maintained: Sell
Price Target: $8 → $9
Current: $31.48
Upside: n/a
Nov 23, 2020
Maintained: Buy
Price Target: $31 → $41
Current: $24.22
Upside: n/a
Nov 13, 2020
Maintained: Hold
Price Target: $167 → $174
Current: $78.71
Upside: n/a
Jul 13, 2020
Initiated Coverage: Hold
Price Target: $51
Current: $52.96
Upside: n/a
Apr 2, 2020
Maintained: Hold
Price Target: $18 → $3
Current: $16.21
Upside: n/a
Nov 16, 2015
Upgraded: Hold
Price Target: n/a
Current: $271.83
Upside: n/a
Sep 21, 2012
Maintained: Buy
Price Target: $36
Current: $184.29
Upside: n/a